Bloom Burton & Co. Inc.

65 Front Street East, Suite 300
Toronto, ON
Canada M5S3A9

Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events.

Recent News

  • Richardson Wealth and Bloom Burton & Co. Announce Strategic Alliance to Expand Wealth Solutions in Healthcare Sector

    Toronto, Ontario--(Newsfile Corp. - February 9, 2021) - RF Capital Group Inc. (TSX: RCG) ("RF Capital") today announced that its wholly owned subsidiary Richardson Wealth Limited ("Richardson Wealth") and Bloom Burton & Co. Inc. ("Bloom Burton"), two of Canada's premier independent financial services firms, have entered into a strategic alliance dedicated exclusively on the healthcare sector. This strategic alliance helps unlock growth potential for both firms. Richardson Wealth expands an already broad shelf of wealth solutions by providing advisors...

    2021-02-09 5:20 PM ET
  • Bloom Burton & Co. Announces the 2021 Bloom Burton Award

    Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2021 Bloom Burton Award and the Bloom Burton Award Gala event to be held at the Four Seasons Hotel in Toronto, Ontario, Canada on Thursday, September 30, 2021. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, investor or policy maker who made the greatest contribution to Canada's innovative healthcare industry in...

    2021-01-25 10:30 AM ET
  • Gordon Keller Receives the 2020 Bloom Burton Award

    Toronto, Ontario--(Newsfile Corp. - November 26, 2020) - Bloom Burton & Co. is pleased to announce Dr. Gordon Keller as the recipient of the 2020 Bloom Burton Award. Dr. Keller's pioneering academic work in the stem cell therapy field led to the founding of BlueRock Therapeutics in 2016, which was ultimately acquired by Bayer for $1 billion in 2019. BlueRock Therapeutics built out a major laboratory in Toronto, where more than 170 world-class scientists have been recruited to bring new...

    2020-11-26 8:15 AM ET
  • The Bloom Burton Healthcare Lending Trust Named Winner in 2020 Canadian Hedge Fund Awards

    Toronto, Ontario--(Newsfile Corp. - October 22, 2020) - The Bloom Burton Healthcare Lending Trust (the "Fund") was named a winner in multiple categories of the 2020 Canadian Hedge Fund Awards (CHFA). Bloom Burton Investment Group Inc. is the manager of the Fund and the Bloom Burton Canadian Healthcare Fund, alternative investment funds that focus on investments in the healthcare sector.The Fund, a private debt fund, won two awards in the private debt category:Best 3-Year ReturnBest 5-Year ReturnThe Canadian Hedge...

    2020-10-22 7:00 AM ET
  • Bloom Burton & Co. Inc. Announces Holdings in Mimi's Rock Corp.

    Toronto, Ontario--(Newsfile Corp. - July 10, 2020) - Bloom Burton & Co. Inc. ("Bloom Burton") announces that, today, 720,240 common share purchase warrants of Mimi's Rock Corp. expired unexercised, resulting in a decrease of holdings to below 10% of the outstanding common shares of Mimi's Rock. Prior to the expiry of these warrants, Bloom Burton, together with its joint actors, beneficially owned, directly and indirectly, 3,507,492 shares and 1,479,240 share purchase warrants representing approximately 6.68% of the outstanding shares on...

    2020-07-10 5:01 PM ET
  • Bloom Burton & Co. Inc. Announces Amendment to Early Warning Report Regarding Mimi's Rock Corp.

    Toronto, Ontario--(Newsfile Corp. - July 29, 2019) - Further to its news release issued on July 26, 2019 announcing its holdings in Mimi's Rock Corp. (TSXV: MIMI) ("Mimi"), Bloom Burton & Co. Inc. ("Bloom Burton") has filed an amended and restated early warning report reflecting the correct number of securities it held prior to the acquisition of 200,000 common shares of Mimi on July 4, 2019. Prior to such acquisition, Bloom Burton beneficially owned, directly and indirectly, 2,893,267 common shares...

    2019-07-29 7:00 AM ET
  • Bloom Burton & Co. Inc. Announces Holdings in Mimi's Rock Corp.

    Toronto, Ontario--(Newsfile Corp. - July 26, 2019) - Bloom Burton & Co. Inc. ("Bloom Burton") announces that it beneficially owns, directly and indirectly, 3,231,867 common shares ("shares") and 1,479,240 share purchase warrants of Mimi's Rock Corp. ("Mimi"), each warrant being exercisable for 1.5 shares representing approximately 6.52% of the outstanding shares on a non-diluted basis and approximately 10.53%% on a partially diluted basis. This press release is being issued pursuant to Canadian early warning requirements because of the acquisition by...

    2019-07-26 7:14 PM ET
  • Bloom Burton & Co. Inc. Announces Holdings in Appili Therapeutics Inc.

    Toronto, Ontario--(Newsfile Corp. - June 24, 2019) - Bloom Burton & Co. Inc. ("Bloom Burton") announces that it beneficially owns, directly and indirectly, 14,350,120 Class A common shares ("shares") and 2,200 broker warrants of Appili Therapeutics Inc. ("Appili") representing approximately 42.79% of the outstanding shares on a non-diluted basis and approximately 42.80% on a partially diluted basis. This press release is being issued pursuant to Canadian early warning requirements because of Appili becoming a reporting issuer and the subsequent acquisition...

    2019-06-24 7:55 AM ET